Total Payments
$7,159
2024 Payments
$2,368
Companies
32
Transactions
194
Medicare Patients
1,457
Medicare Billing
$234,788
Payment Breakdown by Category
Food & Beverage$7,141 (99.7%)
Education$18.51 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,141 | 192 | 99.7% |
| Education | $18.51 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $913.36 | 18 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $782.10 | 19 | $0 (2024) |
| ABBVIE INC. | $737.60 | 37 | $0 (2024) |
| GlaxoSmithKline, LLC. | $725.55 | 12 | $0 (2024) |
| Lilly USA, LLC | $635.79 | 22 | $0 (2024) |
| Novo Nordisk Inc | $574.05 | 9 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $356.96 | 7 | $0 (2024) |
| PFIZER INC. | $329.10 | 12 | $0 (2024) |
| Allergan Inc. | $306.68 | 4 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $227.76 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,368 | 46 | Amgen Inc. ($584.22) |
| 2023 | $1,402 | 40 | Lilly USA, LLC ($271.57) |
| 2022 | $1,086 | 40 | Boehringer Ingelheim Pharmaceuticals, Inc. ($207.63) |
| 2021 | $1,446 | 59 | AbbVie Inc. ($280.57) |
| 2019 | $431.54 | 5 | Allergan Inc. ($181.69) |
| 2018 | $230.58 | 2 | Allergan Inc. ($124.99) |
| 2017 | $195.81 | 2 | Regeneron Healthcare Solutions, Inc. ($124.95) |
All Payment Transactions
194 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $116.42 | General |
| 11/19/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $121.83 | General |
| 11/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: PAIN | ||||||
| 11/12/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: Diabetes Care | ||||||
| 11/11/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: Oncology | ||||||
| 11/01/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: DIABETES | ||||||
| 10/28/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: PAIN | ||||||
| 10/23/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $30.04 | General |
| Category: Bone Health | ||||||
| 10/11/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $33.33 | General |
| Category: VACCINES | ||||||
| 10/03/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: RESPIRATORY | ||||||
| 10/03/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $31.87 | General |
| Category: Neuroscience | ||||||
| 09/27/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $26.40 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $131.10 | General |
| Category: Bone Health | ||||||
| 09/12/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: Inflammation | ||||||
| 09/09/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $29.49 | General |
| Category: VACCINE | ||||||
| 08/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: Diabetes | ||||||
| 08/26/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $26.28 | General |
| Category: Bone Health | ||||||
| 08/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.12 | General |
| Category: DIABETES | ||||||
| 08/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Obesity | ||||||
| 07/30/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $26.32 | General |
| Category: Diabetes | ||||||
| 07/25/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $22.17 | General |
| 07/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $26.98 | General |
| Category: PAIN | ||||||
| 06/28/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: VACCINES | ||||||
| 06/26/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $31.31 | General |
| Category: Inflammation | ||||||
| 06/22/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 442 | 707 | $331,312 | $82,130 |
| 2022 | 11 | 504 | 740 | $322,710 | $80,200 |
| 2021 | 11 | 511 | 698 | $284,974 | $72,459 |
Total Patients
1,457
Total Services
2,145
Medicare Billing
$234,788
Procedure Codes
33
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 131 | 364 | $231,140 | $55,442 | 24.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 59 | 59 | $33,335 | $9,234 | 27.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 61 | 67 | $21,775 | $5,611 | 25.8% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Office | 2023 | 16 | 23 | $9,522 | $2,920 | 30.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $12,320 | $2,769 | 22.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 20 | 27 | $12,420 | $2,629 | 21.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 18 | 18 | $3,780 | $1,295 | 34.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 68 | 76 | $4,560 | $1,040 | 22.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 25 | 25 | $1,500 | $928.50 | 61.9% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 12 | 12 | $720.00 | $194.64 | 27.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 16 | 20 | $240.00 | $68.20 | 28.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 92 | 187 | $118,745 | $29,008 | 24.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 132 | 242 | $111,320 | $26,102 | 23.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 57 | 57 | $32,205 | $8,788 | 27.3% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Office | 2022 | 19 | 32 | $13,248 | $3,847 | 29.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 22 | 22 | $16,940 | $3,616 | 21.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 40 | 44 | $14,300 | $3,592 | 25.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 11 | 11 | $7,282 | $2,732 | 37.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 73 | 81 | $4,860 | $991.77 | 20.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 11 | 11 | $2,310 | $753.94 | 32.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 18 | 18 | $1,080 | $649.64 | 60.2% |
| 81002 | Urinalysis, manual test | Office | 2022 | 29 | 35 | $420.00 | $120.56 | 28.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 158 | 287 | $128,412 | $31,923 | 24.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 56 | 84 | $52,650 | $14,048 | 26.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 43 | 43 | $32,518 | $8,139 | 25.0% |
About Dr. Robert Hardy, M.D
Dr. Robert Hardy, M.D is a Ophthalmology healthcare provider based in Walnut Creek, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2007. The National Provider Identifier (NPI) number assigned to this provider is 1346450418.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Hardy, M.D has received a total of $7,159 in payments from pharmaceutical and medical device companies, with $2,368 received in 2024. These payments were reported across 194 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($7,141).
As a Medicare-enrolled provider, Hardy has provided services to 1,457 Medicare beneficiaries, totaling 2,145 services with total Medicare billing of $234,788. Data is available for 3 years (2021–2023), covering 33 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Internal Medicine
- Location Walnut Creek, CA
- Active Since 05/23/2007
- Last Updated 01/07/2025
- Taxonomy Code 207W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1346450418
Products in Payments
- MOUNJARO (Drug) $526.24
- JARDIANCE (Drug) $526.16
- NURTEC ODT (Drug) $443.65
- EVENITY (Biological) $402.56
- AREXVY (Drug) $275.72
- Wegovy (Drug) $254.37
- TRELEGY ELLIPTA (Drug) $237.28
- SHINGRIX (Biological) $212.55
- VRAYLAR (Drug) $199.39
- UBRELVY (Drug) $191.43
- FARXIGA (Drug) $189.99
- QULIPTA (Drug) $182.38
- LUMIGAN (Drug) $181.69
- Otezla (Drug) $177.52
- Prolia (Biological) $154.35
- XARELTO (Drug) $140.62
- CEQUA (Drug) $125.00
- RESTASIS (Drug) $124.99
- EYLEA AFLIBERCEPT INJECTION (Biological) $124.95
- INVELTYS (Drug) $124.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Walnut Creek
Dr. Roger Goldberg, Md, MD
Ophthalmology — Payments: $1.0M
Ophthalmology $1.0M
Yen Hsia, Md, MD
Ophthalmology — Payments: $503,870
Ophthalmology $503,870
Dr. Caesar Luo, M.d, M.D
Ophthalmology — Payments: $265,271
Ophthalmology $265,271
Shaily Shah, M.d, M.D
Ophthalmology — Payments: $73,102
Ophthalmology $73,102
Dr. Subhransu Ray, M.d., Ph.d, M.D., PH.D
Ophthalmology — Payments: $24,741
Ophthalmology $24,741
Dr. Elizabeth Marlow Lehrburger, M.d, M.D
Ophthalmology — Payments: $10,143
Ophthalmology $10,143